Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

445 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

NCT05365581

Conditions
Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +5 more
Locations
  • University of California Irvine Medical Center Orange, California, United States
  • UCLA Dept of Medicine - Hematology/Oncology, Santa Monica Santa Monica, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
View all 46 locations
View Trial Details
Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

NCT06561685

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +21 more
Locations
  • UCLA Santa Monica, California, United States
  • University of Colorado Health Hospital Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Florida Cancer Specialists ORLANDO/DDU Lake Mary, Florida, United States
View all 33 locations
View Trial Details
Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

NCT05868226

Conditions
Adenocarcinoma, Adenocarcinoma of Colon, Breast Diseases, +51 more
Locations
  • The University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States
  • UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital New Lenox, Illinois, United States
View Trial Details
Recruiting

A Study to Observe the Safety of VYLOY (Zolbetuximab) in People in South Korea With Gastric or Gastroesophageal Junction Cancer.

NCT06902545

Conditions
Adenocarcinoma, Carcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, +6 more
Locations
  • KR82010 Goyang-si, Gyeonggi-do, South Korea
  • KR82008 Suwon, Gyeonggi-do, South Korea
  • KR82009 Suwon, Gyeonggi-do, South Korea
  • KR82006 Yangsan, Gyeongsangnam-do, South Korea
View all 14 locations
View Trial Details
Recruiting

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

NCT07745361

Conditions
Adenocarcinoma, Carcinoma, Castration-Resistant Prostate Cancer (CRPC), +15 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Rocky Mountain Cancer Center Colorado Springs, Colorado, United States
  • Kansas University Cancer Center Kansas City, Kansas, United States
View all 14 locations
View Trial Details
Recruiting

DBC-664 in Adult Patients With Solid Tumors

NCT07705035

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +14 more
Locations
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
  • START New York Lake Success, New York, United States
  • Sarah Cannon Research Institute - Denver HealthONE Denver, Colorado, United States
View Trial Details
Recruiting

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

NCT06844383

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
Locations
  • City of Hope Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Masonic Cancer Center Minneapolis, Minnesota, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions